Romiplostim for SARS-CoV-2 Vaccine Induced Immune Thrombocytopenia.

Abuhelwa, Ziad; Ning, Ying; Abdulsattar, Waleed; Ghazaleh, Sami; Kahlon, Navkirat; Elsayed, Ahmed

Abuhelwa, Ziad; Ning, Ying; Abdulsattar, Waleed; Ghazaleh, Sami; Kahlon, Navkirat; Elsayed, Ahmed.

Abuhelwa Z; Departments of Internal Medicine.
Ning Y; Hematology/Oncology, the University of Toledo, Toledo, OH.
Abdulsattar W; Departments of Internal Medicine.
Ghazaleh S; Departments of Internal Medicine.
Kahlon N; Hematology/Oncology, the University of Toledo, Toledo, OH.
Elsayed A; ProMedica Hematology/Oncology Associates, ProMedica Toledo Hospital, Toledo, Toledo, OH.

Am J Ther ; 28(6): e685-e687, 2021 09 09.

Article in English | MEDLINE | ID: covidwho-1511092

Subject(s)

COVID-19; Purpura, Thrombocytopenic, Idiopathic; COVID-19 Vaccines; Humans; Purpura, Thrombocytopenic, Idiopathic/drug therapy; Receptors, Fc; Recombinant Fusion Proteins; SARS-CoV-2; Thrombopoietin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google